HURA

Tuhura Biosciences Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth 4/10
  • Value 5/10
Tuhura Biosciences sales and earnings growth
HURA Growth
Neutral
  • Revenue Y/Y 0.00%
  • EPS Y/Y 36.46%
  • FCF Y/Y -74.07%
Tuhura Biosciences gross and profit margin trends
HURA Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 5Y 113205.58%
Tuhura Biosciences net debt vs free cash flow
HURA Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -46.3

Tuhura Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks